Carl Dambkowski - Jul 13, 2023 Form 3/A - Amendment Insider Report for Apogee Therapeutics, Inc. (APGE)

Role: Chief Medical Officer
Signature: /s/ Jane Pritchett Henderson, as attorney-in-fact for Carl Dambkowski
Stock symbol: APGE
Transactions as of: Jul 13, 2023
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 7/17/2023, 05:06 PM
Date Of Original Report: Jul 13, 2023
Next filing: Dec 20, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	APGE	Common Stock						301K	Jul 13, 2023	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of (i) 131,992 shares of restricted common stock, one quarter of which will vest on September 16, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, and (ii) 168,796 shares of restricted common stock, one quarter of which will vest on December 14, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, in each case subject to the Reporting Person's continued service to the Issuer.
F2	This amendment is being filed to correct the number of shares reported in Table I due to a calculation error.

Content

Consists of (i) 131,992 shares of restricted common stock, one quarter of which will vest on September 16, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, and (ii) 168,796 shares of restricted common stock, one quarter of which will vest on December 14, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, in each case subject to the Reporting Person's continued service to the Issuer.

This amendment is being filed to correct the number of shares reported in Table I due to a calculation error.